Clinical Trials in Salt Lake City

Showing 641-660 of 16,694 trials

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

NCT05465174

The current study assesses the tolerability and efficacy of monotherapy with pan-RAF-kinase (Tovorafenib) inhibition for the treatment of children and young adults with craniopharyngioma.

Craniopharyngioma, ChildCraniopharyngiomaRecurrent Craniopharyngioma

Sabine Mueller, MD, PhD57 participantsStarted Sep 2022

Birmingham, Alabama, United States • San Diego, California, United States • San Francisco, California, United States +17 more locations

RECRUITINGPhase 2< 1 mile

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

NCT06614322

The goal of this clinical trial is to determine whether quantitative sensory testing (QST) can be used to classify participants into pain sub-groups and predict who will respond best to certain pain treatments in participants with painful peripheral neuropathy. The analgesic effect is evaluated by measuring pain intensity and Patient Global Impression of Change (PGIC). This study is a 3-period cross-over trial. This means researchers will compare 3 different drugs (pregabalin, duloxetine, and placebo) over a period of 19 weeks. Participants will: * Undergo a quantitative sensory testing (QST) exam. * Provide a blood sample. * Complete questionnaires on the computer. * Take the study drug as instructed.

Painful Peripheral NeuropathyDiabetic Peripheral Neuropathic Pain (DPN)Chemotherapy Induced Peripheral Neuropathy (CIPN)+1 more

University of Rochester190 participantsStarted Jan 2026

Boston, Massachusetts, United States • New York, New York, United States • Rochester, New York, United States +4 more locations

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

Find Trials by Condition in Salt Lake City

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

FOG-001 in Locally Advanced or Metastatic Solid Tumors

A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System